CAS 1842427-90-0

FX 2149

CAS: 1842427-90-0

FX 2149 is a GTP-binding inhibitor that potently inhibits LRRK2 GTP binding and kinase activity in vitro and attenuates the toxic effects of LRRK2 in Parkinson’s disease models.

Fórmula: C₁₅H₁₇N₃O₃S

Pureza: 99.94%

Peso molecular: 319.38

Ref: TM-T212761